The cost of life

© Olivier Papegnies
Nous saluons les efforts déployés par les acteurs de la santé mondiale et autres parties prenantes pour mobiliser un soutien financier en faveur de la recherche et développement (R&D), de la fabrication et de la distribution de vaccins et produits diagnostiques et thérapeutiques du coronavirus...
© Olivier Papegnies
We welcome the efforts of the global health actors and other stakeholders to rally financial support to the research and development (R&D), manufacturing and distribution of COVID-19 vaccines, diagnostics and therapeutics through the May 4th global pledging conference 1 .
© Reuters
(Paris, 16/12/2019) On 3 July 2019, the organisations Doctors of the World and Public Eye, represented by Lionel Vial, filed a patent opposition at the European Patent Office against a patent covering Kymriah®, a gene therapy for...
The next generation of gene therapies used for treating cancer are now available on the market – with the first two CAR-T cell therapies priced at 320,000 and 350,000 euros. As was the case with hepatitis C drugs, these exorbitant prices reveal yet again the extent of the financialisation of the...
© Olivier Papegnies
Faced with significant price increases for new drugs, in North and South alike, particularly drugs for cancer, hepatitis C and rare diseases, civil society in France is taking action to defend access to best-quality care for all, and to safeguard the public healthcare system. Several organisations...
Gilead’s price gouging for sofosbuvir blocks millions of people from getting treatment.
© Olivier Papegnies
Faced with significant price increases for new drugs, in North and South alike, particularly drugs for cancer, hepatitis C and rare diseases, civil society in France is taking action to defend access to best-quality care for all, and to safeguard the public healthcare system. Several organisations...
It is no secret that the price of medicines is getting higher and higher, and that these prices are absolutely unjustified. That pharmaceutical companies make huge and contemptable profit margins on treatments for sick people, that the National Health Service cannot maintain. When it comes to...
Les nouveaux médicaments antiviraux à action directe sont certes très efficaces, mais atteignent des prix inquiétants © Reuters
We are all entitled to know about the process involved in pricing a medicine. Let’s not let pharmaceutical laboratories decide on “the price to put on a life” using profitability as criteria.
Today in the UK , doctors have to tell patients that they could cure them using a specific medicine, but cannot prescribe it because it’s too expensive. To avoid the collapse of our health service, the British Government has established selection strategies to decide which patients can benefit from...